Table 4.

Relative risk of lymph node metastasis and outcome according MMR status, p53 expression and L1CAM expression in 312 endometrial carcinomas.

	Lymph node metastasis	recurrence	death	Recurrence and/or death
	RR (95% CI, p)	RR (95% CI, p)	RR (95% CI, p)	RR (95% CI, p)
MMRd	1.06 (0.69–1.64, 0.78)	0.47 (0.22–0.99, 0.05)	1.02 (0.61–1.71, 0.94)	0.60 (0.32–1.14, 0.12)
p53mut	3.06 (2.08–4.50, <0.0001)	5.26 (2.96–9.37, <0.0001)	4.24 (2.24–8.04, <0.0001)	3.85 (2.29–6.46, <0.0001)
L1CAM-positive	2.93 (1.97–4.34, <0.0001)	4.58 (2.53–8.29, <0.0001)	2.43 (1.48–3.96, 0.0004)	3.57 (2.10–6.07, <0.0001)